Protease and Inhibitor Mechanisms
Matrix metalloproteinases are a family of zinc-dependent enzymes that degrade and remodel the extracellular matrix, the structural scaffold surrounding cells, and in doing so they regulate processes ranging from normal tissue repair to the spread of cancer. In malignant disease, MMPs help tumors invade surrounding tissue, stimulate the growth of new blood vessels, and modulate inflammatory signals that shape the tumor microenvironment — while their natural counterparts, the tissue inhibitors of metalloproteinases, work to restrain this activity. The balance between these two forces turns out to be far more complex than a simple on/off switch, since certain MMPs can paradoxically suppress tumor progression depending on context, which has complicated decades of drug development. Current research focuses on understanding the precise spatiotemporal regulation of individual MMP family members and on designing inhibitors selective enough to block harmful activity without disrupting the protective roles these enzymes play in healthy tissue.
- Works
- 76,828
- Total citations
- 1,988,219
- Keywords
- Matrix MetalloproteinasesTissue Inhibitors of MetalloproteinasesCancer ProgressionAngiogenesisExtracellular Matrix RemodelingProtease Inhibition
Top papers in Protease and Inhibitor Mechanisms
Ordered by total citation count.
- Tissue Plasminogen Activator for Acute Ischemic Stroke↗ 11,664
- The pathogenesis of atherosclerosis: a perspective for the 1990s↗ 10,675
- New functions for the matrix metalloproteinases in cancer progression↗ 6,059
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment↗ 5,023OA
- Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases↗ 4,521OA
- Remodelling the extracellular matrix in development and disease↗ 4,334OA
- How Matrix Metalloproteinases Regulate Cell Behavior↗ 3,925OA
- Matrix Metalloproteinases↗ 3,895OA
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation↗ 3,599
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome↗ 3,509OA
- Structure and function of matrix metalloproteinases and TIMPs↗ 3,388
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma↗ 3,351
Active researchers
Top authors in this area, ranked by h-index.